Clinical Trial Update: Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of varenicline on smoking lapse in smokers with and without schizophrenia. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Schizophrenia

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Craving, Smoking | Phase 4 | Status: COMPLETED